[HTML][HTML] Virologic failure of protease inhibitor-based second-line antiretroviral therapy without resistance in a large HIV treatment program in South Africa

JH Levison, C Orrell, S Gallien, DR Kuritzkes, N Fu… - PloS one, 2012 - journals.plos.org
Background We investigated the prevalence of wild-type virus (no major drug resistance)
and drug resistance mutations at second-line antiretroviral treatment (ART) failure in a large …

[PDF][PDF] Virologic Failure of Protease Inhibitor-Based Second-Line Antiretroviral Therapy without

JH Levison, C Orrell, S Gallien, DR Kuritzkes, N Fu - 2012 - pdfs.semanticscholar.org
Background: We investigated the prevalence of wild-type virus (no major drug resistance)
and drug resistance mutations at second-line antiretroviral treatment (ART) failure in a large …

[PDF][PDF] Virologic Failure of Protease Inhibitor-Based Second-Line Antiretroviral Therapy without

JH Levison, C Orrell, S Gallien, DR Kuritzkes, N Fu - 2012 - researchgate.net
Background: We investigated the prevalence of wild-type virus (no major drug resistance)
and drug resistance mutations at second-line antiretroviral treatment (ART) failure in a large …

Virologic Failure of Protease Inhibitor-Based Second-Line Antiretroviral Therapy without Resistance in a Large HIV Treatment Program in South Africa

JH Levison, C Orrell, S Gallien, DR Kuritzkes, N Fu… - PLoS ONE, 2012 - dash.harvard.edu
Background: We investigated the prevalence of wild-type virus (no major drug resistance)
and drug resistance mutations at second-line antiretroviral treatment (ART) failure in a large …

Virologic Failure of Protease Inhibitor-Based Second-Line Antiretroviral Therapy without Resistance in a Large HIV Treatment Program in South Africa.

JH Levison, C Orrell, S Gallien, DR Kuritzkes… - PLoS …, 2012 - search.ebscohost.com
Background: We investigated the prevalence of wild-type virus (no major drug resistance)
and drug resistance mutations at second-line antiretroviral treatment (ART) failure in a large …

Virologic failure of protease inhibitor-based second-line antiretroviral therapy without resistance in a large HIV treatment program in South Africa.

JH Levison, C Orrell, S Gallien, DR Kuritzkes, NS Fu… - 2012 - cabidigitallibrary.org
Background: We investigated the prevalence of wild-type virus (no major drug resistance)
and drug resistance mutations at second-line antiretroviral treatment (ART) failure in a large …

[PDF][PDF] Virologic Failure of Protease Inhibitor-Based Second-Line Antiretroviral Therapy without

JH Levison, C Orrell, S Gallien, DR Kuritzkes, N Fu - 2012 - Citeseer
Background: We investigated the prevalence of wild-type virus (no major drug resistance)
and drug resistance mutations at second-line antiretroviral treatment (ART) failure in a large …

[PDF][PDF] Virologic Failure of Protease Inhibitor-Based Second-Line Antiretroviral Therapy without

JH Levison, C Orrell, S Gallien, DR Kuritzkes, N Fu - 2012 - academia.edu
Background: We investigated the prevalence of wild-type virus (no major drug resistance)
and drug resistance mutations at second-line antiretroviral treatment (ART) failure in a large …

Virologic failure of protease inhibitor-based second-line antiretroviral therapy without resistance in a large HIV treatment program in South Africa

JH Levison, C Orrell, S Gallien, DR Kuritzkes, N Fu… - 2012 - open.uct.ac.za
BACKGROUND: We investigated the prevalence of wild-type virus (no major drug
resistance) and drug resistance mutations at second-line antiretroviral treatment (ART) …

[引用][C] Virologic Failure of Protease Inhibitor-Based Second-Line Antiretroviral Therapy without Resistance in a Large HIV Treatment Program in South Africa

JH Levison, C Orrell, S Gallien, DR Kuritzkes… - PLoS …, 2012 - ui.adsabs.harvard.edu
Virologic Failure of Protease Inhibitor-Based Second-Line Antiretroviral Therapy without
Resistance in a Large HIV Treatment Program in South Africa - NASA/ADS Now on home page …